Waldencast plc

Waldencast plc (Nasdaq: WALD) originated as a blank-check company sponsored by Waldencast Partners LP, completing its initial public offering in 2021 with a stated focus on the global beauty and wellness sector. The vehicle closed its business combination with Obagi Medical Products and Milk Makeup in 2022, converting from a special purpose acquisition company into an operating holding company incorporated as a public limited company under English law. Waldencast plc files with the SEC as a foreign private issuer, most recently submitting a 6-K on April 28, 2026. For complete filing history, sponsor data, and deal analytics on WALD, sign up for full access at SpacDesk.